ProShare Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,898
Closed -$812K 2278
2024
Q4
$812K Buy
15,898
+4,911
+45% +$241K ﹤0.01% 1011
2024
Q3
$453K Buy
10,987
+2,787
+34% +$134K ﹤0.01% 1191
2024
Q2
$395K Sell
8,200
-4,119
-33% -$183K ﹤0.01% 1112
2024
Q1
$591K Buy
12,319
+553
+5% +$29.5K ﹤0.01% 990
2023
Q4
$764K Buy
11,766
+1,925
+20% +$116K ﹤0.01% 832
2023
Q3
$644K Sell
9,841
-52
-0.5% -$3.27K ﹤0.01% 823
2023
Q2
$575K Buy
9,893
+1,077
+12% +$67.9K ﹤0.01% 892
2023
Q1
$544K Sell
8,816
-366
-4% -$22K ﹤0.01% 878
2022
Q4
$584K Buy
9,182
+1,239
+16% +$89.8K ﹤0.01% 890
2022
Q3
$577K Buy
7,943
+654
+9% +$48.7K ﹤0.01% 865
2022
Q2
$496K Buy
7,289
+835
+13% +$60K ﹤0.01% 938
2022
Q1
$584K Sell
6,454
-1,067
-14% -$87.3K ﹤0.01% 1182
2021
Q4
$687K Buy
7,521
+3,163
+73% +$271K ﹤0.01% 1250
2021
Q3
$353K Sell
4,358
-4,461
-51% -$375K ﹤0.01% 1423
2021
Q2
$823K Buy
8,819
+4,397
+99% +$426K ﹤0.01% 1154
2021
Q1
$473K Buy
+4,422
New +$459K ﹤0.01% 1479

Other funds holding NARI

ProShare Advisors's NARI Position: Q1 2025 in Review

ProShare Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 15,898 shares — an estimated $812K sold.

ProShare Advisors first reported a position in NARI in Q1 2021 and held it in 16 quarters. The position peaked at $823K in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • ProShare Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • ProShare Advisors sold 15,898 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $812K.
  • ProShare Advisors first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 16 quarters.
  • ProShare Advisors's Inari Medical, Inc. Common Stock position peaked at $823K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.